A REVIEW OF CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT

Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors in the central nervous program, conolidine modulates alternate molecular targets. A Science Improvements research observed that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, whi